PlainRecalls
FDA Drug Moderate Class II Ongoing

Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13

Reported: January 7, 2026 Initiated: December 30, 2025 #D-0246-2026

Product Description

Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13

Reason for Recall

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Details

Units Affected
96,948 packs
Distribution
Nationwide within the United States
Location
Elmwood Park, NJ

Frequently Asked Questions

What product was recalled?
Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13. Recalled by Glenmark Pharmaceuticals Inc., USA. Units affected: 96,948 packs.
Why was this product recalled?
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 7, 2026. Severity: Moderate. Recall number: D-0246-2026.